Persistence is an enterprise AI Voice Agent platform built for phone-first businesses.
We help organizations build, deploy, manage, and continuously optimize AI voice agents that automate customer conversations across inbound and outbound calls. With deep telephony capabilities, real-time integrations, workflow automation, analytics, and lifecycle management, persistence enables businesses to replace or augment traditional call centers with intelligent AI agents that deliver faster responses, lower operational costs, and exceptional customer experiences at scale.
Rightlander is a market-leading affiliate compliance and reputation management monitor, actively scanning affiliate websites, social media platforms and infringing websites in most countries outside Asia. We are trusted by household names and SMEs alike and we pride ourselves on being the authority in our field.
At present, Rightlander operates principally in the iGaming market however it will be expanding into other affiliate-lead markets during 2020/21
Fully Integrated ERP Solution For Pharma Industry
With the rapid changes in the market condition for the industry, it is necessary for pharma companies to maneuvering skilled and flexible. MetaOption understand the challenges and functioning of the pharmaceutical businesses in depth. Through well-established structured methodologies and tools and techniques, we have delivered micro-verticalized solutions within dedicated time frames to our clients. Gaining greater control is knowing that your system will help drive decision-making processes and enable your people to be more proactive and productive. Microsoft Dynamics NAV delivers the insight you need to monitor business performance from every possible angle.
EBRAND's Online Brand Protection solution enables brand owners to fight infringements, counterfeits, and brand abuse to maintain product integrity. EBRAND's targeted programs secure your intellectual property rights, streamline distribution, protect revenues, and bolster brand presence. The company proactively identifies and mitigates risks, empowering customers to regaining control of their lost revenue.
ARGOS, EBRAND's brand protection platform, delivers an effortless, automated solution fuelled by AI tools and expert support. Additionally, local market experts remain vigilant of current trends and threats. EBRAND offers comprehensive and effective brand protection solutions to boost and protect your brand's reputation online.
Sterlite Tech CSM offers a flexible framework to CSPs for Diameter and Radius stack. It offers a pre-integrated platform that allows operators greater flexibility to facilitate tighter product integration and addresses a wide range of access networks such as FTTH, ADSL, IMS, 2G, Wi-Fi, LTE, 3G & WiMax Interworking.
Brandefense is a proactive digital risk protection solution for organizations. Our AI-driven technology constantly scans the online world, including the dark, deep and surface web, to discover unknown events, automatically prioritize risks and deliver actionable intelligence you can use instantly to improve security.
Ditto Biosciences is a biotechnology company dedicated to developing innovative therapies for autoimmune diseases by harnessing the unique properties of parasite biology. By leveraging artificial intelligence and evolutionary genomics, Ditto Biosciences identifies and engineers proteins from viruses, ticks, and worms into next-generation therapeutics aimed at modulating the human immune system.
Key Features and Functionality:
- AI-Powered Drug Discovery: Utilizes artificial intelligence to analyze and transform parasite-derived proteins into potential therapeutic agents.
- Evolutionary Genomics Integration: Combines evolutionary genomics with AI to understand and leverage the properties of parasite proteins for drug development.
- Targeted Autoimmune Therapies: Focuses on creating solutions to suppress inflammation and remodel tissues, offering innovative treatments for autoimmune conditions.
Primary Value and Problem Solved:
Ditto Biosciences addresses the significant challenge of developing effective treatments for autoimmune diseases, where the immune system mistakenly attacks the body's own tissues. By mining the genomes of parasites that have evolved mechanisms to modulate the human immune response, Ditto Biosciences aims to translate these naturally occurring proteins into novel therapies. This approach offers a promising avenue for creating safe and effective drugs that can restore immune balance in patients suffering from autoimmune disorders.
Proxima is a pioneering biotechnology company dedicated to revolutionizing medicine by making protein interactions programmable. By integrating advanced artificial intelligence with structural biology, Proxima aims to unlock new therapeutic possibilities through precise modulation of protein functions.
Key Features and Functionality:
- Neo-1 Model: Proxima's foundational AI model, Neo-1, unifies structure prediction and molecular design at an atomic level. It enables the design of biomolecules and accelerates structural data collection when combined with the NeoLink platform.
- NeoLink Platform: This innovative structural data generation platform utilizes cross-linking mass spectrometry (XLMS) to measure interatomic distances at scale, providing high-throughput snapshots of structural interactions.
- Integrated Discovery Platform: Proxima combines three complementary, phase-shifting technologies to fully exploit the potential of proximity modulator modalities, facilitating the development of novel therapeutics.
Primary Value and Solutions:
Proxima addresses the challenge of targeting intracellular proteins, which are often inaccessible to traditional therapies. By reprogramming existing cellular proteins and directing them toward new targets using small molecules, peptides, or macrocycles, Proxima enables the treatment of diseases previously considered untreatable. This approach opens a new chapter in medicine, offering hope for patients with limited treatment options.
StaffHero is employee engagement software for lean teams of 25 to 200 people that do not have a big HR department.
Run a short anonymous eNPS℠ pulse survey. Results appear only in groups that reach a reporting threshold of at least five responses, and identity is kept out of everything managers see. Managers can ask a follow-up question about a comment through an anonymous thread without learning who wrote it.
After each eligible round, the AI Leadership Brief summarizes what changed, which themes recur and which areas to look at next. The action tracker turns those next steps into owned actions, so the team can see that feedback led somewhere.
Pricing is flat per package, not per seat: $99 a month for up to 50 employees, $199 for up to 100 and $299 for up to 200, with two months free on annual billing. Create a free account and explore the product in demo mode before you launch a live survey.
Net Promoter, NPS, and the NPS-related emoticons are registered U.S. trademarks, and Net Promoter Score, Net Promoter System and eNPS are service marks, of Bain & Company, Inc., NICE Systems, Inc. and Fred Reichheld.
TATEEDA designs, develops, quality-tests, and delivers custom software for U.S. and Canadian healthcare, pharma, biotech, and other regulated businesses, from initial architecture through production support. The team specializes in HIPAA-compliant systems: EHR/EMR integrations (Epic, Oracle Health/Cerner), FHIR and HL7 data exchange, patient portals, remote patient monitoring, medical billing and claims processing, and healthcare HR/staffing platforms, built primarily on .NET/C#, Angular, React Native, and Node.js and deployed on Azure and AWS. Engagements begin with a direct technical assessment led by TATEEDA's CTO — not a sales handoff — so architecture and compliance requirements are scoped before a team is assigned. Delivery is staffed exclusively by TATEEDA's own senior engineers (no freelancers), drawn from delivery hubs across 16 countries, with dedicated project managers who track scope, budget, and QA cycles and adjust design based on client feedback throughout the build. TATEEDA has shipped production healthcare systems for clients including AYA Healthcare (travel-nurse workforce platform), La Maestra Community Health Centers (patient portal), and SCRx Pharmacy (claims automation), and has been named to the Inc. 5000 four times (2022–2025).
CheckRed is an all-encompassing cloud security solution that gives organizations unparalleled visibility into all facets (SaaS, IaaS, PaaS) of their security posture. With an emphasis on simplicity, complete visibility, scanning & alerting capabilities, and efficient remediation workflows, CheckRed makes it easier for companies to protect their environments and focus on what matters most; growing their business.
CloudPassage is a security and compliance automation platform designed to provide instant visibility and continuous protection for servers in any combination of data centers, private clouds and public clouds.
RADAR™ enables organizations and governments to maintain the uninterrupted business continuity of online services. Using RADAR™'s patented vulnerability simulation technology, enterprises have unparalleled visibility into their DDoS protection solutions so they can be confident that damaging DDoS attacks can be prevented - before they happen.
Fraudfinder is an AI-powered fraud detection platform that analyses documents in under 3 seconds to identify manipulation, forgery, and risk at scale.
Fraudfinder supports document fraud checks and ID checks across bank statements, payslips, utility bills, proof-of-address files, and identity documents, including native PDFs, images, and AI-generated or synthetic documents.
Our holistic approach combines document forensics, data extraction and enrichment, external data validation, and behavioural analysis to detect fraud that rules-based or single-signal tools miss. Results are delivered via API or dashboard with clear, explainable risk indicators teams can trust.
Fraudfinder is used across lending, tenant screening, client onboarding and ongoing monitoring, claims management, and auditing. In addition to reducing fraud risk, it helps operations teams save time, reduce manual reviews, and scale decision-making without increasing headcount.
Trusted by regulated and non-regulated organisations, Fraudfinder enables businesses to avoid financial losses, fines, and regulatory breaches, meet compliance obligations, and operate confidently in the age of Gen-AI.
Enterprise Threat Protector (ETP) enables security teams to proactively identify, block, and mitigate targeted threats such as malware, ransomware, phishing, and data exfiltration that exploit the Domain Name System (DNS). Powered by real-time intelligence from Akamai Cloud Security Intelligence and Akamai's proven, globally distributed recursive DNS platform, Enterprise Threat Protector efficiently delivers security, control, and visibility to the enterprise while easily integrating with your existing network defenses.
Ripple Effect Communications, located in Boston, New York, and California, is the digital PR company that has changed the face of public relations. Ripple Effect offers content marketing, integrated communications, and influencer relations for the benefit of its clients. We use an innovative infrastructure, executive-only talent pool with client-side experience, and a unique pricing structure to result in lean, yet target-exceeding performance.
Managing B2B PR and digital marketing communications campaigns in high technology industries such as manufacturing, healthcare, medical devices, biotech, food & beverages, and fintech, our senior team of marketing and PR professionals provides strategic direction, counsel, and implementation across the entire range of client requirements. We bring multi-lingual capabilities as well as global connections as part of Eurocom Worldwide, one of the largest global PR agency networks.
Flexibility, scalability, and a focus on results are at the heart of every one of our services. Each service can be full scale or scaled back at any time. Other services can be added or removed as needed to create the most innovative, creative digital PR program that works. Best of all, every service is tied to an accountability matrix, which is our guarantee on results as well as a tactical action plan for the effective delivery of services, including access to industry experts for strategy and media relations.
Merit GxP Documents is a comprehensive document management and control solution tailored for life science organizations, including biotech, pharmaceutical, and medical device companies. It facilitates the entire document lifecycle—from creation and development to review, publishing, change management, and archival—ensuring compliance with GxP guidelines, ISO standards, and FDA 21 CFR Part 11 regulations.
Key Features and Functionality:
- Tight Document Control: Utilizes predefined document types to maintain consistent structure, manages documentation per GxP standards, and supports the complete document lifecycle.
- Secure Collaboration: Enables internal and external teams to collaborate effectively within a cloud-based workspace with role-based security, ensuring clear accountability and separation of responsibilities.
- Integration with Microsoft Azure: Built on Microsoft Azure, providing comprehensive security, compliance, and scalability.
- Audit Trails and E-Signatures: Maintains robust audit trails and supports electronic signatures to meet regulatory requirements.
Primary Value and User Solutions:
Merit GxP Documents addresses the critical need for life science organizations to manage controlled documents efficiently while ensuring regulatory compliance. By automating document management processes, it reduces reliance on paper-based systems, minimizes errors, and accelerates approval cycles. The solution enhances data integrity, supports successful regulatory filings, and facilitates secure collaboration with partners, thereby improving overall operational efficiency and compliance readiness.
ImmunoPrecise Antibodies Ltd. (IPA is a biotechnology company specializing in the discovery and development of therapeutic antibodies. Leveraging advanced artificial intelligence through its proprietary LENS^{ai}™ platform, IPA offers comprehensive, end-to-end antibody discovery services. These services encompass target analysis, immunization, antibody discovery and characterization, developability profiling, optimization, engineering, and preclinical services. By integrating AI-driven methodologies with traditional laboratory techniques, IPA accelerates the development of highly targeted and effective biotherapeutics.
Key Features and Functionality:
- AI-Driven Discovery: Utilizes the LENS^{ai}™ platform to analyze vast biological datasets, identifying optimal antibody candidates with enhanced precision.
- Comprehensive Services: Offers a full suite of services from target analysis to preclinical development, ensuring a seamless transition through each stage of antibody development.
- Proprietary Technologies: Employs unique platforms such as B-cell Select™ for efficient antibody screening and DeepDisplay for custom immune library construction.
- Customization and Optimization: Provides tailored solutions, including antibody humanization, affinity maturation, and developability profiling to meet specific therapeutic needs.
Primary Value and Problem Solved:
IPA addresses the complexities and inefficiencies in traditional antibody discovery by integrating AI and proprietary technologies, significantly reducing development timelines and costs. This approach enhances the precision and efficacy of therapeutic antibodies, offering solutions for unmet medical needs and advancing the field of biotherapeutics.